Invention Grant
US08236556B2 Method of modulating gene expression using an ecdysone receptor-based inducible gene expression system
有权
使用基于蜕皮激素受体的诱导型基因表达系统调节基因表达的方法
- Patent Title: Method of modulating gene expression using an ecdysone receptor-based inducible gene expression system
- Patent Title (中): 使用基于蜕皮激素受体的诱导型基因表达系统调节基因表达的方法
-
Application No.: US11841597Application Date: 2007-08-20
-
Publication No.: US08236556B2Publication Date: 2012-08-07
- Inventor: Marianna Zinovjevna Kapitskaya , Subba Reddy Palli
- Applicant: Marianna Zinovjevna Kapitskaya , Subba Reddy Palli
- Applicant Address: US VA Blacksburg
- Assignee: Intrexon Corporation
- Current Assignee: Intrexon Corporation
- Current Assignee Address: US VA Blacksburg
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- Main IPC: C12N15/00
- IPC: C12N15/00
Abstract:
This invention relates to the field of biotechnology or genetic engineering. Specifically, this invention relates to the field of gene expression. More specifically, this invention relates to a novel ecdysone receptor/chimeric retinoid X receptor-based inducible gene expression system and methods of modulating gene expression in a host cell for applications such as gene therapy, large-scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation of traits in transgenic organisms.
Public/Granted literature
Information query
IPC分类:
